Progress in the development of malaria vaccines: Context and constraints

Parassitologia

Volumn 41, Issue 1-3, 1999, Pages 429-432

  Brown, G V ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Concomitant immunity; Global strategy; Malaria; Product profile; Vaccine efficacy

Indexed keywords

MALARIA VACCINE;

HUMAN; REVIEW;

HUMANS; MALARIA VACCINES;

EID: 0033182322     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Alonso PL, Lindsay SW, Armstrong JR, Conteh M, Hill AG, David PH, Fegan G, de Francisco A, Hall AJ, Shenton FC, et al. (1991). The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet 337: 1499-1502.
2. Brown GV (1997). Fighting malaria. A new campaign for the next millenium. Br Med J 314: 1707-1708.
3. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K (1998) Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nature Med 4: 358-360.
4. Coggeshall LT (1940). The occurrence of malaria antibodies in human serum following induced infection with Plasmodium knowlesi J Exp Med 72: 21-31.
5. Cohen S, McGregor IA, Carrington SC (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
6. Collins WE, Warren M, Skinner JC, Richardson BB, Chin W (1979) Studies on the West African I strain of Plasmodium falciparum in Aotus trivirgatus monkeys J Parasitol 65: 763-767.
7. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM (1991). Common West African HLA antigens are associated with protection from severe malaria. Nature 352: 595-600.
8. Nevill CG, Some ES, Mung'ala VO, Mutemi W, New L, Marsh K, Lengeler C, Snow RW (1996) Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast Trop Med Int Health 1 139-146.
9. Reeder JC, Cowman AF, Davern KM, Beeson JG, Thompson JK, Rogerson SJ, Brown GV (1999). The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by PfEMP1 Proc Natl Acad Sci USA 96: 5198-5202.
10. Rogerson SJ, Brown GV (1997). Chondroitin sulfate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes. Parasitol Today 13: 70-75.
11. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD (1996). Glycosylphosphatidylinositol toxin of Plasmodium upregulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 156: 1886-1896.
12. Snow RW, Omunbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, Weber MW, Pinder M, Nahlen B, Obonyo C, Newbold C, Gupta S, Marsh K (1997). Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa Lancet 349: 1650-1654
13. Snow RW, Peshu N, Forster D, Bomu G, Mitsanze E, Ngumbao E, Chisengwa R, Schellenberg JR, Hayes RJ, Newbold CI, Marsh K (1998). Environmental and entomological risk factors for the development of clinical malaria among children on the Kenyan coast. Trans R Soc Trop Med Hyg 92: 381-385.
14. Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K, Glenn G, Ockenhouse CF, Garcon N, Schwenk R, Lanar DE, Sun P, Momin P, Wirtz RA, Golenda C, Slaoui M, Wortmann G. Holland C, Dowler M, Cohen J, Ballou WR (1998) Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis 178 1139-1144.
15. Wilson RJM, Phillips RS (1976). Method to test inhibitory antibodies in human sera to wild populations of Plasmodium falciparum Nature 263 132-134.
16. World Health Organization (1993a). A global strategy to control malaria WHO, Geneva.